DanyalIbrahimMDMPH

Emergency Medicine • Hartford, CT

Medical Toxicology

Regional Chief Quality Officer, Trinity Health Of New England Associate Professor, Emergency Medicine, Quinnipiac Netter School of Medicine

Join to view full profile

Dr. Ibrahim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ibrahim's full profile

Already have an account?

Office
114 Woodland St
Hartford, CT 06105
Phone+1 860-714-5155

Education & Training

Indiana University School of MedicineFellowship, Medical Toxicology (Emergency Medicine), 2004 - 2006
Washington University/B-JH/SLCH ConsortiumResidency, Emergency Medicine, 2001 - 2004
University of Toronto Faculty of MedicineClass of 1997

Certifications & Licensure

WI State Medical License 2024 - 2025
CT State Medical License 2005 - 2024
IN State Medical License 2004 - 2011
HI State Medical License 2003 - 2003
American Board of Emergency Medicine Emergency Medicine
American Board of Emergency Medicine Medical Toxicology

Publications & Presentations

PubMed

1 citations
Impact of a hospital unit-based leadership triad on key performance metrics
Michael R. Grey, Gagandeep Singh, Danyal Ibrahim, Schawan Kunupakaphun, Caroline Segovia-Marquez
Hospital Practice. 2021-01-12
9 citations
Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial.
Danyal Ibrahim, Latha Dulipsingh, Lisa Zapatka, Reginald Eadie, Rebecca Crowell
Infectious Diseases and Therapy. 2020-12-01
8 citations
Erratum: This Article Corrects: "Identifying Patients at Greatest Risk of Mortality due to COVID-19: A New England Perspective".
Aaron A. Smith, Jeremy Fridling, Danyal Ibrahim, Paul S. Porter Jr.
The Western Journal of Emergency Medicine. 2020-09-28

Press Mentions

Trinity Health Announces Plasma Clinical Trial ResultsSeptember 30th, 2020
Clinical Trial Results on COVID-19 Convalescent Plasma Treatment by Trinity Health of New EnglandSeptember 30th, 2020
Study: Use of Convalescent Plasma on Critically Ill COVID-19 Patients Significantly Increases Recovery RatesSeptember 28th, 2020
Join now to see all